Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-Vax vs Placebo with IL-2 in Stage IV Melanoma
NCT00477906Phase 3Unknown
- Sponsor
- AVAX Technologies, Inc.
- Start
- Jul 2016
- Primary completion
- Jan 2019
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 3 trial of M-Vax in melanoma, sponsored by AVAX Technologies, Inc.. Status: unknown.
02
Drugs
M-Vax
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00477906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477906.